2000
DOI: 10.1001/archpsyc.57.12.1139
|View full text |Cite
|
Sign up to set email alerts
|

Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers

Abstract: The NMDARs are critically involved in human MMN generation. Deficient MMN in schizophrenia thus suggests deficits in NMDAR-related neurotransmission. N-methyl-D-aspartate receptor dysfunction may also contribute to the impairment of patients with schizophrenia in forming and using transient memory traces in more complex tasks, such as the AX-CPT. Thus, NMDAR-related dysfunction may underlie deficits in transient memory at different levels of information processing in schizophrenia. Arch Gen Psychiatry. 2000;57… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

35
400
6
7

Year Published

2000
2000
2011
2011

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 553 publications
(448 citation statements)
references
References 80 publications
35
400
6
7
Order By: Relevance
“…In nonhuman primates, NMDAR antagonists selectively abolish the generation of MMN without affecting sensory ERPs such as N1 (Javitt et al, 1992(Javitt et al, , 1994(Javitt et al, , 1996. Likewise, we recently demonstrated that the NMDAR antagonist ketamine induces a significant reduction of MMN, but not of N1, in healthy volunteers (Umbricht et al, 2000). Similarly, ketamine and other NMDAR antagonists significantly reduced MMNm (the magnetic counterpart of MMN) and MMN, respectively, in healthy volunteers (Jääskeläinen et al, 1995a(Jääskeläinen et al, , b, 1996Kreitschmann-Andermahr et al, 2001;Pang and Fowler, 1999).…”
Section: Introductionmentioning
confidence: 82%
See 2 more Smart Citations
“…In nonhuman primates, NMDAR antagonists selectively abolish the generation of MMN without affecting sensory ERPs such as N1 (Javitt et al, 1992(Javitt et al, , 1994(Javitt et al, , 1996. Likewise, we recently demonstrated that the NMDAR antagonist ketamine induces a significant reduction of MMN, but not of N1, in healthy volunteers (Umbricht et al, 2000). Similarly, ketamine and other NMDAR antagonists significantly reduced MMNm (the magnetic counterpart of MMN) and MMN, respectively, in healthy volunteers (Jääskeläinen et al, 1995a(Jääskeläinen et al, , b, 1996Kreitschmann-Andermahr et al, 2001;Pang and Fowler, 1999).…”
Section: Introductionmentioning
confidence: 82%
“…Similarly, ketamine and other NMDAR antagonists significantly reduced MMNm (the magnetic counterpart of MMN) and MMN, respectively, in healthy volunteers (Jääskeläinen et al, 1995a(Jääskeläinen et al, , b, 1996Kreitschmann-Andermahr et al, 2001;Pang and Fowler, 1999). In addition, subanesthetic doses of ketamine induce a pattern of deficits in AX-CPT performance in healthy volunteers that is characterized by a specific increase of context-dependent (BX) errors and closely resembles the deficits observed in schizophrenia (Umbricht et al, 2000). Thus, the available evidence suggests that in schizophrenia NMDAR-related dysfunction may contribute significantly to abnormalities in context-dependent information processing both at preattentive automatic and at attention-dependent controlled levels.…”
Section: Introductionmentioning
confidence: 88%
See 1 more Smart Citation
“…These agents uniquely induce symptoms resembling the negative and disorganized symptoms of schizophrenia and produce schizophrenia-like information processing deficits by interacting with cortical NMDA receptors (Krystal et al, 1994;Lahti et al, 1995;Malhotra et al, 1996;Umbricht et al, 2000). However, it remains unknown whether NMDA receptor dysfunction, of itself, would be sufficient to account for the dopaminergic hyperactivity associated with the disorder.…”
Section: Introductionmentioning
confidence: 99%
“…Few data are available concerning the influence of neurotransmitter systems on the MMN. In a single-blind placebo-controlled study, Umbricht et al (2000) have suggested that N-methyl-D-aspartate receptors (NMDAR) were critically involved in the human MMN because the NMDAR antagonist keta-mine significantly decreased the peak amplitude of the MMN. These results indicated that glutamatergic activity could be involved in the genesis of the MMN.…”
Section: Introductionmentioning
confidence: 99%